Prof. Piotr Durka got his degrees from the Faculty of Physics, University of Warsaw (UW), where he created the Poland's first brain-computer interface (BCI) in 2008, and world's first Neuroinformatics curriculum in 2009. In 2012 founded BrainTech Ltd, delivering Poland's first complete (hardware and software) and commercially available BCI systems. Currently continues research on BCI and disorders of consciousness (DoC) at UW, and leads R&D project in machine translation using artificial neural networks at Patpol Ltd. List of papers, books and other details at http://durka.info.

Dr. Żaneta Świderska-Chadaj is a Professor at Warsaw University of Technology and an expert in applying artificial intelligence to the analysis of medical and biological image data. Her work focuses on developing AI solutions that improve medical diagnostics (histopathological and radiological) and deepen the understanding of biological processes. Her interdisciplinary research combines AI and computer vision with biology and medicine. Dr. Świderska-Chadaj also leads a research group at the IDEAS Research Institute and, since 2024, has been a member of the Polish Young Academy of Sciences. She has gained international research experience in the Netherlands, Spain, and the United States, and is a recipient of prestigious awards, including the START FNP award, the Minister's Scholarship, and the Polityka Scientific Award.

Professor Tomasz Kajdanowicz obtained his M.Sc. and Ph.D. degrees, both with distinction, from Wrocław University of Science and Technology in 2008 and 2012, respectively. His doctoral dissertation was awarded the title of Best Polish Doctoral Dissertation (2012/2013) by the Polish Section of the European Association for Artificial Intelligence in 2014.

Professor Kajdanowicz has served as principal investigator and project leader in more than 40 research and development projects, including prestigious initiatives funded by the European Union, the National Science Centre (NCN), the National Centre for Research and Development (NCBR), and the Foundation for Polish Science (FNP), as well as numerous industrial projects.

He has acted as co-chair and member of organising and program committees for numerous international conferences, workshops, and summer schools in the fields of artificial intelligence and machine learning (including NeurIPS, ACL, AAAI, and ICLR). Moreover, he co-organised panel sessions within the AI House 2025 initiative at the World Economic Forum in Davos.

Professor Kajdanowicz is the author of over 170 scientific publications covering topics such as recommender systems, representation learning, large language models, multi-agent systems, and applications of artificial intelligence in law and medicine. He has conducted research at Stanford University (USA), the University of Notre Dame (USA), and the Technical University of Dortmund (Germany), and has served as a visiting professor at the University of Technology Sydney (Australia).

A designer and researcher of digital products with nearly 20 years of experience. He began in the 2000s as a business website designer at nf.pl and later as a designer at GG Network.

Since 2012, he has run Uxeria, the largest research and design company in Poland, which collaborates with key market players on strategic challenges. He has worked on systems such as biznes.gov.pl and Obywatel.gov.pl with the Ministry of Entrepreneurship, the Patient Online Account with CSIOZ (currently CEZ), and the European Funds Website System in Poland with the Ministry of Funds and Regional Policy. He has also collaborated with some of the largest companies on the market, developing and implementing digital product development strategies – including LuxMed, Medicover, Pfizer, Adamed, Novartis, Orlen, Dom Development, and dozens of others.

One of the founders and an active member of the NIL IN Physicians Innovators network, established by the Supreme Medical Chamber. He collaborates regularly with the District Medical Chamber in Warsaw to improve the quality of physician experience. He is building a system that serves as a blueprint for innovation in the medical field: searchmed.eu. He is an active mentor of acceleration programs such as Google Launchpad, HugeThing, and GovTech (under the Ministry of Entrepreneurship). He is a member of the Supervisory Board of an investment fund operating in the renewable energy sector. 

He is a recognized speaker at leading Polish and European industry conferences, including the Economic Forum in Karpacz, UX Poland, ProducCamp, Forum IAB, Mobile Trends Conference, World Usability Day, and most leading medical conferences. He has been frequently cited by publications such as Gazeta Lekarska, Puls Biznesu, and Interaktywnie, and has been a guest on numerous podcasts, including Nietylko.Design, Apploads, and many others.

Dr. Iwo Zmyślony is an innovation-culture designer and an anthropologist of emerging technologies. He serves as a trainer and business advisor at ICAN Institute. He earned his PhD from the University of Warsaw with a dissertation on creativity in the empirical sciences.

He is the author of numerous scholarly publications in the psychology and sociology of knowledge (know-how, tacit knowledge), as well as critical essays on experimental culture. He teaches in the postgraduate Neuro-Leadership and MBA programs at Łazarski University and serves on the Scientific Council of the Human for Future Foundation.

He also hosts the podcast “Limity AI” (“AI Limits”), available on the MIT Sloan Management Review Poland channels.

Łukasz Więch is a physician - specialist in public health with over 15 years of experience in clinical research and extensive expertise in healthcare management. He currently serves as the Medical Director at clinicaltrials sites network Trialmed, where he is responsible for developing medical teams, ensuring research quality, and safeguarding patient safety in clinical trials.

As a leader of healthcare studies at Kozminski University, he has educated more than 2,000 graduates in health management and clinical research, shaping future leaders in the healthcare sector.

A motivated Pharmacy student at Jagiellonian University Collegium Medicum with a research focus on anticancer drug development. Her experience spans both in silico drug design and organic synthesis, offering a comprehensive background in pharmaceutical research and development. She has presented her findings at two international scientific conferences.

President of Digital Poland Association

As the President of Digital Poland Association, he has been representing the largest manufacturers and distributors of electrical and electronic equipment in Poland for 20 years. Connected with Digital Europe, an organization of Europe's largest association of the ICT sector, where holds the position of Board Member. Chosen by the Minister of Digital Affairs of Poland to take a seat in the ministry’s Council for Digitization. The initiator of the CEE Digital Coalition – the digital industry coalition from Central and Eastern Europe.

PhD in Law and legal counsel since 2014, specializing in European Union law, medical law, international law, and new technologies. Research interests include Poland’s cooperation with the EU, protection of human rights (with particular focus on migrant issues), and questions of ethics and liability in medical practice. Since 2020, member of the International Law Committee at the Warsaw Bar Association, engaged in the development and promotion of international law. Author of numerous publications on medical law, human rights, and EU law, including works on large language models (ChatGPT, Claude, Microsoft Copilot) and the potential of AI in legal contexts.

Trainer for legal, medical, educational, and pharmaceutical sectors, demonstrating practical applications of large language models and AI tools in professional practice. Expert with Team Europe (European Commission), advising on regulatory and ethical challenges of AI across sectors. Lecturer in postgraduate programs at SWPS University, focusing on practical applications of artificial intelligence. Holder of the Masters of Didactics certificate, combining traditional and innovative approaches to legal education.

Marek Zapalski is a member of the GCP community with over 16 years of experience working for the Life Sciences industry, delivering innovative solutions that bridge science, technology, and data. Currently, he supports global clients at DataForce by providing advanced Data and AI services that enhance efficiency, accuracy, and innovation across clinical and research operations.

Andrzej Kinasiewicz is a passionate leader in new technologies, artificial intelligence, automation, and data science, with deep expertise in clinical research, risk management, monitoring, and data quality. He co-developed Risk-Based Monitoring (RBM) at AstraZeneca and serves as Director of Central Monitoring. He contributes to the decentralized clinical trial initiative Trials@Home, and globally implemented a clinical-site risk management framework he co-authored. He also represented AstraZeneca in the TransCelerate initiative.

A trained pharmacist, he graduated from the Faculty of Pharmacy at the Medical University of Warsaw and Friedrich-Wilhelm-Universität Bonn (Germany). He holds a PhD in pharmaceutical sciences from Medical University of Warsaw and previously led a research group at the Polish Academy of Sciences, Institute of Biocybernetics and Biomedical Engineering.  He also completed postgraduate studies in psychology at the Warsaw School of Economics (SGH), complementing his technical and scientific background with a strong understanding of human behavior and decision-making.

Paulina Wawro is a Senior Clinical Data Scientist at AstraZeneca, specializing in Centralized Monitoring. She designs and builds tools that make risk-based monitoring of clinical trials smarter and more efficient. With more than four years in her current role, Paulina has become especially intrigued by the promise of AI in clinical research—an interest that took off after her experience at the WAICoE Hackathon in 2024. Her scientific journey started in molecular biology, leading to a PhD in neuroscience in Japan and a postdoc at Stanford University focused on Parkinson’s disease. Moving from academia to pharma, Paulina now combines her passion for innovative technology with a drive to improve trial outcomes.

Magdalena Stafińska is a graduate of the Medical University of Silesia. She is an independent Development Technologist at KAMSOFT S.A., specializing in the design and implementation of innovative technological solutions in the medical and pharmaceutical sectors. She has worked at KAMSOFT S.A. for 14 years. In her work, she combines technological and substantive knowledge with a practical approach to IT systems development. During the AI in Pharma Innovation Summit conference, she will present a speech entitled "The 'Machine' serving Doctors is not the future – it's the present of digital medicine", in which she will show how AI already supports doctors and pharmacists in their daily practice.

I’m a dedicated and passionate innovator in healthcare technology, serving as co-founder and CTO at CliniNote. With a passion for enhancing patient care through streamlined communication and documentation, I try to leverage my expertise to design intuitive solutions that empower healthcare professionals and allow to boost research at the same time.

I am also an Associate Professor at Nalecz Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences. My main research focusing is on mathematical modelling of pulse wave propagation in the arterial tree under different pathological conditions, i.e. in case of patients with end stage renal disease or with traumatic brain injury. The idea is that using mathematical modelling we can improve currently existing methods of cardiovascular system state assessment.

PhD in Law and legal counsel since 2014, specializing in European Union law, medical law, international law, and new technologies. Research interests include Poland’s cooperation with the EU, protection of human rights (with particular focus on migrant issues), and questions of ethics and liability in medical practice. Since 2020, member of the International Law Committee at the Warsaw Bar Association, engaged in the development and promotion of international law. Author of numerous publications on medical law, human rights, and EU law, including works on large language models (ChatGPT, Claude, Microsoft Copilot) and the potential of AI in legal contexts.

Trainer for legal, medical, educational, and pharmaceutical sectors, demonstrating practical applications of large language models and AI tools in professional practice. Expert with Team Europe (European Commission), advising on regulatory and ethical challenges of AI across sectors. Lecturer in postgraduate programs at SWPS University, focusing on practical applications of artificial intelligence. Holder of the Masters of Didactics certificate, combining traditional and innovative approaches to legal education.

Tomasz is a mathematician–turned computational biologist and drug hunter who has spent the past decade in the pharma and biotech industries. As an academic, he explored high-content screening applications at the interface of systems biology and statistical learning. He then joined Insilico Medicine as an ML and bioinformatics scientist, pioneering AI-driven projects in target identification, drug repurposing, and lab automation; he co-developed PandaOmics and contributed to the AI-designed TNIK inhibitor rentosertib, now in Phase 2/3 trials. After serving as Director of AI & Data Science at Ardigen - where he partnered with dozens of leading biotech and pharma companies - he joined Ingenix as Lead Scientist. He continues to integrate omics, imaging, chemical, and biological data to streamline clinical development and push AI×Bio solutions to the next level.

Dr. Artem Andrianov is an internationally recognized leader in data-driven quality management for clinical trials. As the CEO and co-founder of Cyntegrity, he has shaped how sponsors and CROs operationalize ICH E6(R3) principles through validated, AI-powered RBQM and QbD frameworks.

With over 25 years of experience across the pharmaceutical and technology sectors, Dr. Andrianov bridges scientific rigor with operational innovation. His expertise spans biostatistics, data quality assurance, spirometry, ECG, oncology, and ePROs, helping organizations transform compliance into competitive advantage.

Holding a Ph.D. in Mathematical Modelling and an Executive MBA from Cass Business School, London, he brings both analytical depth and strategic vision to every presentation. A frequent speaker at global forums, Dr. Andrianov is known for translating complex regulatory and statistical concepts into actionable strategies that make clinical trials safer, faster, and inspection-ready. 

AI Consultant specializing in strategy, communication, and business. Host of the "99 faces of AI" podcast.